Magnova 1000mg/125mg Injection
Marketer
Lupin Ltd
Salt Composition
Cefepime (1000mg) + Tazobactum (125mg)
Overview Magnova 1000mg/125mg Injection
Combiflox 1000 mg/125 mg Injection combines two antibiotics to combat diverse bacterial infections. Its mechanism involves inhibiting microbial proliferation. Administration must be under a doctor's guidance; strict adherence to the prescribed dosage schedule is crucial, completing the entire course regardless of symptom improvement. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and localized injection site reactions (redness, swelling, pain), typically resolving spontaneously. Severe or worsening side effects warrant immediate medical attention. Allergic reactions (rash, itching, swelling, respiratory distress) require urgent medical help. Prior to use, disclose all current medications and pre-existing health conditions to your physician. This is especially important for pregnant or breastfeeding individuals. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't affect driving ability, refrain from driving if experiencing drowsiness or dizziness.
Primary Ingredients of Magnova 1000mg/125mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Magnova 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Magnova 1000mg/125mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Magnova 1000mg/125mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Magnova 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Magnova 1000mg/125mg Injection works:
Magnova Injection (1000 mg/125 mg) unites cefepime, a potent antibiotic, with tazobactam, a beta-lactamase inhibitor. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Tazobactam counteracts bacterial enzymes that otherwise degrade cefepime, thereby improving cefepime's efficacy and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol alongside Magnova 1000 mg/125 mg Injection requires careful consideration. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Magnova 1000 mg/125 mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administering Magnova 1000 mg/125 mg Injection while breastfeeding is considered safe. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Following administration of Magnova 1000 mg/125 mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
For individuals with kidney impairment, administering Magnova 1000 mg/125 mg Injection requires careful consideration. Dosage modification of Magnova 1000 mg/125 mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
For individuals with liver conditions, Magnova 1000 mg/125 mg Injection appears to be well-tolerated. Existing evidence indicates dose modification might not be necessary, but physician consultation is recommended.
What if you forget to take Magnova 1000mg/125mg Injection :
Should you inadvertently omit a scheduled dose of Magnova 1000 mg/125 mg Injection, seek medical advice.
Facts to Know About Magnova 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
3,018 People bought this recently